beta
IA Trial Radar

Mostrando ensayos clínicos para glp1 Agonist.

Puedo ayudarle a entender sus condiciones de salud, tratamientos o encontrar ensayos clínicos cercanos.
Nuestra herramienta de búsqueda solo admite inglés. Para búsquedas y discusiones en otros idiomas, use la IA Trial Radar o seleccione los filtros de condición médica y ubicación a continuación.
99 resultados
Mostrando los 50 primeros
 
Estado (Por defecto)
Aún No Recluta, Reclutando, Activo, No Reclutando
×
 
Condición médica
glp1 Agonist
×
 
Intervención
GLP-1
×
 
Título del estudio
Estado
Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery (Maigrir_OT) NCT06278285
Reclutando
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists NCT07224880
Reclutando
GLP-1 RA on Liver OMICS in MASLD NCT06982378
Aún no recluta
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy NCT06903923
Reclutando
Impact GLP-1 Agonists Following Bariatric NCT06132477
Reclutando
Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer NCT07314528
Aún no recluta
The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality NCT07127354
Reclutando
Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) Agonist Prior to Anesthesia NCT06654219
Reclutando
Effects of Beginning a GLP1-Agonist Therapy on Residual Gastric Content and Gastric Emptying (GLP-1) NCT06659159
Aún no recluta
Effect of GLP-1 Receptor Agonists on Body Composition in Obesity: The Role of Dietary Protein Consumption in Muscle Mass Maintenance (LEAN-PRO GLP-1) NCT07495904
Reclutando
Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users (aGLP1-GUS) NCT06987669
Aún no recluta
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse NCT07419854
Reclutando
Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery (GEM-GLP1RA) NCT07100691
Aún no recluta
Strength Training Response of Muscle in GLP-1 Users (STRONG-GLP) NCT07104539
Reclutando
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness NCT06487832
Reclutando
Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy NCT07175805
Aún no recluta
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists NCT07325435
Activo, no reclutando
Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions (COMO-1) NCT06867718
Activo, no reclutando
Evaluate the Detection of Retained Gastric Contents and Assess Safety Using the Flower Capsule Endoscopy in Healthy Individuals and GLP-1 Receptor Agonist Users NCT06927401
Aún no recluta
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS) NCT07169136
Reclutando
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes (DECLARED-CT) NCT06715514
Reclutando
Terapia con agonistas del receptor del péptido 1 similar al glucagón (GLP-1) y entrenamiento físico en personas con obesidad NCT07091500
Reclutando
Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes" (TOLEDDO) NCT05305794
Reclutando
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance NCT04731272
Reclutando
Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment NCT06069622
Reclutando
A Study of a Weight Loss Intervention in People With Endometrial Cancer NCT06751589
Reclutando
Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment (PROBIO-GLP1) NCT07213323
Aún no recluta
Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity (PLASTIC) NCT07021937
Aún no recluta
Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist NCT06666049
Reclutando
Comparison of Body Composition Changes With Weight Loss Interventions (REFORM) NCT07115069
Reclutando
The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination NCT03878706
Reclutando
Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss. (OBA) NCT07411378
Aún no recluta
Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT) NCT07457424
Activo, no reclutando
CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users NCT06467604
Activo, no reclutando
GLP-1 and Hyperoxia for Organ Protection in Heart Surgery (GLORIOUS) NCT02673931
Activo, no reclutando
Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass (GLIMMER) NCT07272837
Aún no recluta
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study) NCT07083154
Reclutando
¿La semaglutida mejora los síntomas depresivos en pacientes con trastorno depresivo mayor y sobrepeso u obesidad? (SEMAMOOD) NCT07136714
Reclutando
Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk (SIPPA-QH_HHC-2) NCT07032311
Aún no recluta
Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis (RADIANT) NCT07282041
Reclutando
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients NCT06774079
Reclutando
GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery (GLUMINS) NCT06324461
Reclutando
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder (CRAVE) NCT07218354
Aún no recluta
Estudio de BMF-650 en participantes adultos con sobrepeso u obesidad por lo demás sanos NCT07223216
Reclutando
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia NCT07107334
Reclutando
Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment (BICEP) NCT07226947
Reclutando
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes NCT06706284
Reclutando
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss (PLATEAU) NCT07446998
Reclutando
Weight Loss Management in Endometrial Cancer Survivors (ECS Weight) NCT06877572
Reclutando
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US NCT07431086
Reclutando